Lee's Pharmaceutical Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LPCUF research report →
About the company
Lee's Pharmaceutical Holdings Limited functions as an investment holding company primarily focused on the development, manufacturing, and commercialization of pharmaceutical products within the People's Republic of China. The company's therapeutic scope is broad, addressing various medical conditions across diverse areas such as cardiovascular health, women's health, pediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. Its business operations are structured into two main segments: Proprietary and Generic Products, and Licensed-In Products.
- CEO
- Siu Fong Lee
- IPO
- 2021
- Employees
- 1,022
- HQ
- Sha Tin, HK
Price Chart
- Market Cap
- $112.06M
- P/E
- 6.79
- P/S
- 0.43
- P/B
- 0.31
- EV/EBITDA
- 2.95
- Div Yield
- 4.25%
- Gross Margin
- 50.81%
- Op Margin
- 5.99%
- Net Margin
- 6.40%
- ROE
- 4.65%
- ROIC
- 2.33%
- Revenue
- $1.44B · 2.55%
- Net Income
- $91.92M · -1.27%
- EPS
- $0.16 · 0.00%
- Op Income
- $61.47M
- FCF YoY
- 194.16%
- 52W High
- $0.20
- 52W Low
- $0.19
- 50D MA
- $0.19
- 200D MA
- $0.19
- Beta
- 0.56
- Avg Volume
- 3.89K
Get TickerSpark's AI analysis on LPCUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LPCUF coverage
Recent articles, reports, and earnings notes.
No research on LPCUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LPCUF report →Similar companies
Peers in the same neighborhood.